Psychiatry for Teens

Treatment Approaches

When teens need a psychiatrist — and what ‘need’ actually means

There’s a wide gap between a teen who’s struggling and a teen who genuinely needs a child and adolescent psychiatrist. The line isn’t pain — every teen has hard moments — but specific clinical situations where psychiatric expertise materially changes outcomes. Here’s how to think about the threshold.

There is a wide gap between a teen who is struggling and a teen who needs a child and adolescent psychiatrist. Most struggling teens are best served by a good therapist, sometimes with the pediatrician handling first-line medication. Specialty psychiatric care is genuinely needed in a smaller and more specific set of situations.

The line that makes a teen need a psychiatrist isn’t pain or family distress — every adolescence includes those — but specific clinical features where psychiatric expertise materially changes outcomes. This article maps those features.

The three professionals — what each role is for, in adolescence

Therapist. Master’s-level — LCSW, LMFT, LPC. Provides weekly talk therapy. For adolescents, the primary modalities are CBT (the best-studied treatment for anxiety, depression, and OCD), DBT (for emotion-regulation difficulties, often appropriate when there is self-harm), family-based therapy (FBT for eating disorders, attachment-based for mood), and interpersonal therapy (IPT-A for adolescent depression). Cannot prescribe. The clinician your teen sees most.

Psychologist. Doctoral-level — PsyD or PhD. Two main subgroups in adolescent mental health: those who deliver evidence-based therapy at doctoral level (often the right call for complex therapy presentations or specialized modalities), and those who perform psychological testing (comprehensive assessment for ADHD, autism, learning disability, complex diagnostic presentations). Cannot prescribe in most US states.

Psychiatrist. MD or DO with psychiatry residency. A child and adolescent psychiatrist did an additional one- or two-year fellowship in working with people under 18. Provides evaluation and medication management. In most modern practices, the psychiatrist does not deliver weekly therapy — that work is done by a separate therapist, with the two clinicians coordinating. The psychiatrist enters when medication is genuinely indicated, when diagnostic uncertainty needs specialty resolution, or when symptoms are beyond the scope of pediatric primary care.

The 5 clinical situations where psychiatry is genuinely indicated

Specialty adolescent psychiatric care meaningfully improves outcomes — and is worth seeking proactively rather than waiting — in roughly five situations:

1. Moderate-to-severe major depression. Not the diagnosis-by-internet kind, but the kind that meets clinical criteria: persistent depressed mood or anhedonia for at least two weeks, with significant functional impairment, and frequently with associated symptoms (sleep, appetite, concentration, hopelessness, suicidal ideation). The TADS trial showed combination treatment (fluoxetine plus CBT) outperformed either alone for adolescent depression. Severe depression often warrants psychiatric involvement from the start.

2. Suicidality, including non-suicidal self-injury. Active suicidal ideation with intent or plan, recent suicide attempt, recurrent self-injury that is not improving with therapy alone. Psychiatric evaluation is indicated, and inpatient or higher-level-of-care assessment may be required. This is not a wait-list situation.

3. Suspected bipolar disorder. The differential between adolescent unipolar depression and bipolar I or II is genuinely difficult and high-stakes — the treatments differ, and the wrong treatment for bipolar (antidepressant monotherapy) can precipitate mania. Family history of bipolar disorder, post-pubertal mood-cycling presentations, and treatment-resistant depression all push toward psychiatric assessment.

4. OCD that interferes with daily function. Obsessive-compulsive disorder in adolescents is highly responsive to specific treatment (exposure and response prevention plus, often, an SSRI), but the optimal treatment plan benefits from specialty-level expertise — both because the diagnosis is under-recognized and because medication titration in pediatric OCD differs from adult patterns.

5. Treatment-resistant or comorbid presentations. Anxiety with depression, ADHD with mood symptoms, eating disorders with depression, substance use with anxiety. Combinations are common and require a clinician comfortable with the interaction effects of treatment plans across multiple diagnoses. The TORDIA trial established that adolescents with SSRI-resistant depression benefit from a combined switch — adding CBT alongside a different medication — which is the kind of plan that ought to be designed by psychiatry.

The lower-threshold situations — straightforward anxiety, mild-to-moderate depression, uncomplicated ADHD — are usually well-served by the pediatrician-plus-therapist model, with psychiatry available as backup if those treatments aren’t enough.

What an evaluation actually looks like

A first child and adolescent psychiatry evaluation is typically 60 to 90 minutes:

  1. Pre-visit history. Forms covering developmental history, family psychiatric history, current symptoms, school functioning, prior providers and treatments, current medications, allergies. Many practices ask for school records and prior treatment summaries in advance.
  2. Time with parents. The psychiatrist gathers history from you, uninterrupted, with the teen out of the room.
  3. Time with the teen alone. Standard practice and developmentally important. Teens often disclose meaningful information to a clinician they wouldn’t disclose to a parent, including substance use, self-injury, or sexual identity issues that affect treatment planning. Confidentiality is bounded by safety.
  4. Synthesis with the family. Initial impression, the differential diagnosis, and a recommended plan.
  5. Documentation. A written assessment is sent to the referring pediatrician (and to your therapist if you have one) within a few days.

A first visit may or may not result in a prescription. Many evaluations end with “let’s gather more data” — additional rating scales, school observations, ruling out medical mimics — before any treatment is recommended.

The medication conversation, demystified

Medication for adolescent psychiatric conditions is, in general:

  • Effective. SSRIs help roughly 40–60% of adolescents with anxiety or depression respond meaningfully (vs. 25–35% on placebo). Stimulants help roughly 70–80% of adolescents with ADHD respond well to one of them.
  • Reversible. Almost all psychiatric medications used in adolescents are designed for time-limited courses, not lifelong commitment. Many conditions remit and the medication tapers off.
  • Monitored. The black-box warning on antidepressants for young people is about a small but real increase in suicidal ideation in the first weeks. The clinical response is close monitoring during that window — weekly check-ins, clear plans — not avoiding effective treatment for severe symptoms.

The conversation about whether to medicate isn’t between hope and harm. It’s between two competing risks: the risk of an effective treatment with side effects, and the risk of leaving severe symptoms untreated. A good psychiatrist will discuss both transparently and let the family weigh in.

Therapy plus medication is usually the answer

The major adolescent treatment trials (TADS for depression, CAMS for anxiety, MTA for ADHD, POTS for OCD) converge on a similar finding: for moderate-to-severe presentations, combination treatment outperforms either modality alone. The standard care model is:

  • A therapist providing weekly evidence-based therapy
  • A psychiatrist evaluating and managing medication
  • The pediatrician in the loop on overall medical care
  • The family as observers, partners in the treatment plan, and context-holders

Choosing between therapy and medication, when both are clearly indicated, is rarely the right move. The right move is sequencing — which to start first, when to add the second.

What to ask at the first visit

A short list:

  1. What’s your differential diagnosis? A psychiatrist who has considered the alternative diagnoses is the one you want.
  2. What’s your treatment plan, including the plan B? A coherent plan for what to do if the first medication or dose doesn’t work.
  3. How will we coordinate with the therapist? Releases of information, shared treatment goals, communication frequency.
  4. What are the warning signs you want us to watch for? Specifically. Side effects, mood changes, behavioral changes.
  5. How do we reach you between visits if something changes? Phone, patient portal, on-call coverage after hours.

When to seek a second opinion

Routine and reasonable, especially:

  • Before starting a long-term medication
  • After a few months on a medication that hasn’t worked as expected
  • When a serious diagnosis (bipolar, psychosis) has been raised
  • When the family doesn’t feel heard

A second adolescent psychiatrist or a developmental pediatrician can provide one. Most clinicians welcome second opinions — defensiveness about them is itself a yellow flag.

The short version

Specialty adolescent psychiatric care is genuinely needed for moderate-to-severe depression, suicidality, suspected bipolar, OCD with functional impairment, and complex comorbid presentations. For everything else, the pediatrician-plus-therapist model is usually the right starting point, with psychiatry available as escalation. Combination treatment (therapy plus medication) outperforms either alone for most moderate-to-severe presentations. Second opinions are normal and welcome.

Talk to an Emora therapist matched to your goals. In-network with most major insurance.

Find a therapist

Frequently asked

It shouldn’t be. Earlier psychiatric involvement, especially when symptoms cross specific thresholds, often shortens the total length of treatment and reduces the chance of complications. ‘Last resort’ framing tends to mean a teen is sicker by the time they reach competent care than they had to be.

A child and adolescent psychiatrist completed a one- or two-year fellowship after general psychiatry residency, focused on developmental, pharmacologic, and family-system considerations specific to people under 18. For prescribing in this age group — especially the SSRI black-box warning, the bipolar-or-depression differential, and stimulant management — the difference is real.

Well-targeted medication, used at the right dose for the right diagnosis, returns teens to themselves rather than changing who they are. The teen you remember from before symptoms began is usually who you get back. If a medication makes a teen feel ‘not like myself,’ that’s a signal to tell the prescriber — it usually means dose adjustment or a different medication.

Developmentally, a lot. A 14-year-old has different consent dynamics, different baseline brain maturation, often different presenting symptoms (more behavioral expression of mood), and different family-system involvement. A 17-year-old is closer to adult prescribing patterns, has more autonomy in treatment decisions, and is often planning for the transition to adult care. Both need a clinician who works with adolescents specifically.

The truth, calibrated to their developmental level. Frame it as a specialist consult — the same way you’d frame a referral to any other doctor. Acknowledge any embarrassment without dismissing it. Make clear it’s an evaluation, not a foregone prescription. Most teens are more relieved than embarrassed once they understand what the visit is.

Sources cited

Read our full editorial standards.

Keep reading

More from Psychiatry for Teens